查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1820648

全球抗爱滋病毒药物市场研究报告 - 产业分析、规模、份额、成长、趋势及预测（2025 年至 2033 年）

Global Anti-retroviral Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格

全球抗爱滋病毒药物市场预计将大幅成长，到 2033 年将达到 529.8 亿美元，高于 2024 年的 356.2 亿美元。预计 2025 年至 2033 年期间该市场的年复合成长率(CAGR) 为 4.51%。

受持续的爱滋病毒/爱滋病疫情以及联合疗法和长效製剂的进步推动，全球抗逆转录病毒药物市场有望稳步增长。整合酶抑制剂和进入抑制剂等新型药物类别正在改善病毒抑制效果并提高患者依从性。未来的发展将着重于注射和植入式给药系统，以及针对病毒库的潜在治癒策略。

此外，透过全球健康倡议扩大中低收入国家的治疗可近性，正在扩大患者覆盖范围。数位化依从性监测与远距医疗的整合正在提升治疗效果。监管审批和专利到期正在影响市场动态。随着爱滋病毒治疗的进步，抗爱滋病毒药物市场将持续创新，提供更安全、更有效、更方便的疗法。

目录

第一章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第三章：抗爱滋病毒药物－产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按产品进行市场吸引力分析
    • 按类型分析市场吸引力
    • 按年龄层分析市场吸引力
    • 按配销通路分析市场吸引力
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第五章：全球抗爱滋病毒药物市场分析：按产品

  • 按产品概览
  • 按产品进行历史和预测资料分析
  • 蛋白酶抑制剂
  • 整合酶抑制剂
  • 多类别组合产品
  • 核苷逆转录酶抑制剂（NRTIS）
  • 非核苷逆转录酶抑制剂（NRTIS）
  • 其他药物类别

第六章：全球抗爱滋病毒药物市场分析：依类型

  • 按类型概览
  • 按类型分析历史和预测数据
  • 品牌
  • 通用的

第七章：全球抗爱滋病毒药物市场分析：依年龄组

  • 按年龄组别概览
  • 按年龄组别进行的历史和预测资料分析
  • 成人
  • 儿科
  • 老年

第 8 章：全球抗爱滋病毒药物市场分析：按分销管道

  • 按配销通路概览
  • 按配销通路进行历史和预测资料分析
  • 医院药房
  • 零售药局
  • 网路药局

第九章：全球抗爱滋病毒药物市场分析：按地区

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第 10 章：抗爱滋病毒药物公司的竞争格局

  • 抗爱滋病毒药物市场竞争
  • 伙伴关係/合作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • AbbVie Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Boehringer Ingelheim International GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bristol-Myers Squibb Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cipla
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • F. Hoffmann-La Roche Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Gilead Sciences Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GlaxoSmithKline Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Johnson & Johnson
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck & Co. Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Viatris Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，或者在私人公司的情况下可能不涵盖

Product Code: VMR112113942

Global Anti-retroviral Drugs Market is poised to witness substantial growth, reaching a value of USD 52.98 Billion by the year 2033, up from USD 35.62 Billion attained in 2024. The market is anticipated to display a Compound Annual Growth Rate (CAGR) of 4.51% between 2025 and 2033.

The global anti-retroviral drugs market is set for steady growth driven by the ongoing HIV/AIDS epidemic and advancements in combination therapies and long-acting formulations. Novel drug classes, including integrase inhibitors and entry inhibitors, are improving viral suppression and patient adherence. Future developments will focus on injectable and implantable delivery systems, as well as strategies targeting viral reservoirs for potential cure.

Additionally, expanding access to treatment in low- and middle-income countries through global health initiatives is broadening patient coverage. The integration of digital adherence monitoring and telehealth is enhancing treatment outcomes. Regulatory approvals and patent expirations are influencing market dynamics. As HIV care advances, the anti-retroviral drugs market will continue to innovate, delivering safer, more effective, and accessible therapies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Anti-retroviral Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Protease Inhibitors
  • Integrase Inhibitors
  • Multi-Class Combination Products
  • Nucleoside Reverse Transcriptase Inhibitors (NRTIS)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NRTIS)
  • Other Drug Classes

By Type

  • Branded
  • Generic

By Age Group

  • Adult
  • Pediatric
  • Geriatric

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • List of Companies Profiled in the report
  • AbbVie Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cipla, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Viatris Inc.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ANTI-RETROVIRAL DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By Age Group
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTI-RETROVIRAL DRUGS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Protease Inhibitors Historic and Forecast Sales By Regions
  • 5.4. Integrase Inhibitors Historic and Forecast Sales By Regions
  • 5.5. Multi-Class Combination Products Historic and Forecast Sales By Regions
  • 5.6. Nucleoside Reverse Transcriptase Inhibitors (NRTIS) Historic and Forecast Sales By Regions
  • 5.7. Non-Nucleoside Reverse Transcriptase Inhibitors (NRTIS) Historic and Forecast Sales By Regions
  • 5.8. Other Drug Classes Historic and Forecast Sales By Regions

6. GLOBAL ANTI-RETROVIRAL DRUGS MARKET ANALYSIS BY TYPE

  • 6.1. Overview By Type
  • 6.2. Historical and Forecast Data Analysis By Type
  • 6.3. Branded Historic and Forecast Sales By Regions
  • 6.4. Generic Historic and Forecast Sales By Regions

7. GLOBAL ANTI-RETROVIRAL DRUGS MARKET ANALYSIS BY AGE GROUP

  • 7.1. Overview By Age Group
  • 7.2. Historical and Forecast Data Analysis By Age Group
  • 7.3. Adult Historic and Forecast Sales By Regions
  • 7.4. Pediatric Historic and Forecast Sales By Regions
  • 7.5. Geriatric Historic and Forecast Sales By Regions

8. GLOBAL ANTI-RETROVIRAL DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Hospital Pharmacy Historic and Forecast Sales By Regions
  • 8.4. Retail Pharmacy Historic and Forecast Sales By Regions
  • 8.5. Online Pharmacy Historic and Forecast Sales By Regions

9. GLOBAL ANTI-RETROVIRAL DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANTI-RETROVIRAL DRUGS COMPANIES

  • 10.1. Anti-retroviral Drugs Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF ANTI-RETROVIRAL DRUGS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. AbbVie Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Boehringer Ingelheim International GmbH
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Bristol-Myers Squibb Company
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Cipla
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. F. Hoffmann-La Roche Ltd.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Gilead Sciences Inc.
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. GlaxoSmithKline Plc
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Johnson & Johnson
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Merck & Co. Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Pfizer Inc.
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Viatris Inc
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Protease Inhibitors Market Sales By Geography (USD MN)
  • Integrase Inhibitors Market Sales By Geography (USD MN)
  • Multi-Class Combination Products Market Sales By Geography (USD MN)
  • Nucleoside Reverse Transcriptase Inhibitors (NRTIS) Market Sales By Geography (USD MN)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NRTIS) Market Sales By Geography (USD MN)
  • Other Drug Classes Market Sales By Geography (USD MN)
  • Analysis By Type (USD MN)
  • Branded Market Sales By Geography (USD MN)
  • Generic Market Sales By Geography (USD MN)
  • Analysis By Age Group (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Geriatric Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacy Market Sales By Geography (USD MN)
  • Retail Pharmacy Market Sales By Geography (USD MN)
  • Online Pharmacy Market Sales By Geography (USD MN)
  • Global Anti-retroviral Drugs Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Anti-retroviral Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Anti-retroviral Drugs Market Size, By Regions (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Age Group
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Protease Inhibitors Market Sales By Geography (USD MN)
  • Integrase Inhibitors Market Sales By Geography (USD MN)
  • Multi-Class Combination Products Market Sales By Geography (USD MN)
  • Nucleoside Reverse Transcriptase Inhibitors (NRTIS) Market Sales By Geography (USD MN)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NRTIS) Market Sales By Geography (USD MN)
  • Other Drug Classes Market Sales By Geography (USD MN)
  • Global Market Analysis By Type (USD MN)
  • Branded Market Sales By Geography (USD MN)
  • Generic Market Sales By Geography (USD MN)
  • Global Market Analysis By Age Group (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Geriatric Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacy Market Sales By Geography (USD MN)
  • Retail Pharmacy Market Sales By Geography (USD MN)
  • Online Pharmacy Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.